Agilent Technologies Expands Microarray Service Provider Network
SANTA CLARA, Calif., Dec. 13, 2006
Agilent Technologies Inc. (NYSE: A) today announced that it has signed two new partners and recertified one more as Certified Microarray Service Providers for Agilent microarrays. Each of these organizations received certifications after their laboratories completed training and passed a rigorous set of assessments that included proficiency in analyzing Agilent 60-mer oligo microarrays using the complete Agilent system.
“These three companies, and indeed all of our Certified Microarray Service Providers, together play a valuable role in extending our reach around the world, further enabling the power of Agilent Technologies,” explains Agilent marketing manager Kevin Meldrum. “This is an important expansion of Agilent’s Certified Service Provider program, which was founded in 2004.”
“It’s gratifying to see the program catch fire in key regions around the world where important research involving microarrays is being conducted,” Meldrum adds. “We very much look forward to working with our new certified providers and to continuing our productive relationship with our newly recertified providers in the months and years to come.”
* Empire Genomics LLC, Buffalo, NY, a new firm focusing on technologies to enable personalized medicine, driven by the research of Roswell Park Cancer Institute researcher Norma Nowak, Ph.D. This company offers a wide range of best-in-class products and analytical services on its array-based comparative genomics platform to characterize chromosomal abnormalities.
* Welgene Biotech Co. Ltd., Taipei City, Taiwan, focusing on microarray analysis and real-time PCR technology research. Founded in 2004, it is a subsidiary of medical device distributor Welmore Co., Ltd.
* ExonHit Therapeutics, Paris, France, with a facility in Gaithersburg, Maryland, is a world-leading company in the field of alternative RNA splicing, the naturally occurring biological process by which a single gene can lead to several transcripts and proteins. Its SpliceArrays make use of extensive, specific probe sets and provide an exhaustive monitoring of gene expression.
The system around which training is centered includes sample quality control using the Agilent 2100 Bioanalyzer, sample labeling using Agilent reagents and protocols, hybridization using SureHyb chambers, microarray analysis using the Agilent scanner and feature extraction software, and final data-analysis using the GeneSpring bioinformatics platform.
Agilent is a leading worldwide provider of microarray-based genomics solutions. It provides research tools that enable scientists to study a wide range of applications including gene expression, alternative splicing, chromosomal aberrations and gene copy number (aCGH), protein/DNA interactions (ChIP on Chip) and DNA methylation. The microarrays for these applications are available as either catalog products or custom designs configured through Agilent’s eArray design portal. For further details about Agilent’s microarray solutions, visit www.OpenGenomics.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.0 billion in fiscal year 2006. Information about Agilent is available on the Web at www.agilent.com.
- Contact Information
- John Watson
- Agilent Technologies Inc.
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.